Oversea-Chinese Banking Corp (OCBC)’s Gilead Sciences GILD Stock Holding History

Oversea-Chinese Banking Corp (OCBC)’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$831K	Buy	5,962 +3,478	+140%	+$487K	0.02%	242
2025 Q4	$305K	Buy	+2,484	New	+$302K	0.01%	289
2025 Q2	–	Sell	-3,291	Closed	-$369K	–	364
2025 Q1	$369K	Sell	3,291 -3,962	-55%	-$409K	0.01%	315
2024 Q4	$670K	Buy	+7,253	New	+$653K	0.02%	255
2024 Q3	–	Sell	-11,880	Closed	-$817K	–	400
2024 Q2	$817K	Buy	11,880 +8,397	+241%	+$560K	0.02%	243
2024 Q1	$254K	Buy	+3,483	New	+$268K	0.01%	333
2023 Q4	–	Sell	-15,862	Closed	-$1.19M	–	353
2023 Q3	$1.19M	Buy	+15,862	New	+$1.22M	0.05%	184
2023 Q2	–	Sell	-10,125	Closed	-$840K	–	347
2023 Q1	$840K	Buy	10,125 +6,907	+215%	+$572K	0.04%	183
2022 Q4	$276K	Buy	+3,218	New	+$255K	0.02%	302

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Oversea-Chinese Banking Corp (OCBC)'s GILD Position: Q1 2026 in Review

Oversea-Chinese Banking Corp (OCBC) increased its Gilead Sciences (GILD) stake by 140% in Q1 2026, buying an estimated $487K and bringing the position to 5,962 shares worth $831K. The position accounts for 0.02% of the portfolio, ranked #242.

Oversea-Chinese Banking Corp (OCBC) first reported a position in GILD in Q4 2022 and has held it in 9 quarters since. The position peaked at $1.19M in Q3 2023. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Oversea-Chinese Banking Corp (OCBC) held 5,962 shares of Gilead Sciences worth $831K as of Q1 2026.
Oversea-Chinese Banking Corp (OCBC) bought 3,478 Gilead Sciences shares in Q1 2026, an estimated $487K.
Gilead Sciences made up 0.02% of Oversea-Chinese Banking Corp (OCBC)'s portfolio in Q1 2026, its #242 holding.
Oversea-Chinese Banking Corp (OCBC) first reported a position in Gilead Sciences in Q4 2022 and has held it in 9 quarters since.
Oversea-Chinese Banking Corp (OCBC)'s Gilead Sciences position peaked at $1.19M in Q3 2023.
2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Oversea-Chinese Banking Corp (OCBC)'s 13F filing for Q1 2026, filed 28 Apr 2026.